{
    "nctId": "NCT00898690",
    "briefTitle": "Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer",
    "officialTitle": "Determination Of FEZ1/LZTS1 Expression As A Predictor Of Response To Taxol",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Evaluation of the association between tumor expression of FEZ1/LZTS1 gene and response to paclitaxel",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Diagnosis of breast cancer\n* Measurable disease\n\n  * Metastatic disease identified by imaging studies OR a primary disease site that will be treated in a neoadjuvant protocol\n  * Lesions \u2265 10 mm by spiral CT scan\n* Tumor tissue from the primary or metastatic site available for analysis by immunohistochemistry\n* Previously treated OR planning to undergo treatment with paclitaxel\\* NOTE: \\*Concurrent enrollment on ECOG-2100 allowed\n* Hormone receptor status:\n\n  * Not specified\n\nPATIENT CHARACTERISTICS:\n\n* Not specified\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}